Pediatric Cardiology • Parent Guide
Genetics & Congenital Heart Disease
One of the questions parents ask most quietly — and deserve a clear answer to.
📚 Moss & Adams, 10th Ed. | AHA Scientific Statement on Genetic Basis of CHD (2018) | GeneReviews, NCBI
👨⚕️ Pediatric Cardiology / Clinical Genetics
KEY STATS
| 3–5% | 25–50% | 30% | ~1% |
|---|---|---|---|
| Recurrence risk if one parent has CHD (vs 0.8% baseline) | Of CHDs have an identifiable genetic cause | Of CHDs associated with a chromosomal syndrome | General population risk of having a child with any CHD |
🫀 Is Congenital Heart Disease Genetic?
The answer is: sometimes — and it depends on the specific diagnosis.
Congenital heart disease is not a single condition. It is a group of over 100 different structural heart defects, each with its own cause, pattern, and inheritance. Some CHDs have a strong genetic basis. Others are caused by environmental exposures during pregnancy. Most are multifactorial — a combination of genetic predisposition and environmental factors that we cannot fully identify.
Understanding the genetics of your child’s specific diagnosis is important — not just for them, but for planning your own family and theirs in the future.
Three Categories of CHD by Cause
1. Chromosomal Syndromes (~15% of CHD)
These involve a missing, extra, or rearranged chromosome. The heart defect is one feature of a broader syndrome.
| Syndrome | Chromosomal Abnormality | Common Heart Defects |
|---|---|---|
| Down syndrome | Trisomy 21 | AVSD (40–50%), VSD, ASD, PDA |
| Turner syndrome | 45,X (monosomy X) | Bicuspid aortic valve, coarctation of aorta |
| DiGeorge / 22q11 deletion | 22q11.2 microdeletion | TOF, interrupted aortic arch, VSD, truncus |
| Williams syndrome | 7q11 deletion | Supravalvar aortic stenosis, peripheral PS |
| Noonan syndrome | RAS pathway variants | Pulmonary stenosis, HCM, ASD |
| Trisomy 13 / 18 | Extra chromosome 13 or 18 | Severe complex CHD — multiple defects |
In most chromosomal syndromes, the recurrence risk is low (determined by the specific chromosomal mechanism). However, 22q11.2 deletion is autosomal dominant — a parent with 22q11 deletion has a 50% chance of passing it to each child.
2. Single-Gene (Monogenic) Defects (~5–10% of CHD)
A mutation in a single gene causes the heart defect, often as part of a syndrome. These follow predictable inheritance patterns.
| Condition | Gene | Inheritance | Risk to Children |
|---|---|---|---|
| Hypertrophic cardiomyopathy (HCM) | MYH7, MYBPC3, others | Autosomal dominant | 50% per child |
| Long QT syndrome | KCNQ1, KCNH2, SCN5A, others | Autosomal dominant | 50% per child |
| Marfan syndrome | FBN1 | Autosomal dominant | 50% per child |
| Holt-Oram syndrome | TBX5 | Autosomal dominant | 50% per child |
| Alagille syndrome | JAG1, NOTCH2 | Autosomal dominant | 50% per child |
For autosomal dominant conditions, every child of an affected person has a 1-in-2 chance of inheriting the gene variant — regardless of sex.
3. Multifactorial CHD (~80% of CHD)
The majority of isolated CHDs (VSD, ASD, TOF, PDA, AVSD without Down syndrome, TGA, etc.) are multifactorial — caused by the interaction of multiple genetic variants and environmental factors during early fetal heart development.
There is no single gene to test. Instead, there is a recurrence risk — the empirical probability of CHD occurring again in a family.
| Situation | Approximate Recurrence Risk |
|---|---|
| One affected sibling, parents normal | 2–3% (vs. 1% population risk) |
| Two affected siblings, parents normal | 5–10% |
| One affected parent (mother) | 4–6% |
| One affected parent (father) | 2–3% |
| One affected parent + one affected sibling | 10–15% |
💡 Why Is Maternal CHD a Higher Risk Than Paternal?
When the mother has CHD, the recurrence risk in her children is roughly twice that when the father has CHD. This is not fully understood but may relate to the intra-uterine environment — a mother’s cardiac condition can subtly alter placental blood flow and fetal oxygen delivery during the critical weeks of heart formation.
When Should Genetic Testing Be Considered?
| Indication | Recommended Testing |
|---|---|
| CHD + developmental delay + dysmorphic features | Chromosomal microarray (CMA) |
| TOF, interrupted aortic arch, truncus arteriosus | FISH or CMA for 22q11 deletion |
| HCM, LQTS, dilated cardiomyopathy | Targeted gene panel |
| Marfan / connective tissue features | FBN1 sequencing |
| Complex CHD with multiple affected family members | Exome sequencing |
| Consanguinity (related parents) | CMA + consider recessive gene panel |
| Healthy parents wanting recurrence risk counselling | Referral to clinical genetics |
Fetal Echocardiography — Monitoring Future Pregnancies
If a parent or a sibling has CHD, the next pregnancy should include a fetal echocardiogram performed by a specialist, typically around 20–22 weeks of gestation. This is the best tool for detecting significant CHD before birth.
Benefits of fetal echo:
- Detects most major structural heart defects prenatally
- Allows planning of delivery at or near a cardiac centre
- Prepares the family and the team before birth
- Enables early intervention (e.g., PGE₁) immediately after delivery if needed
Not all CHDs are detectable on routine obstetric ultrasound — a dedicated fetal echo by a trained fetal cardiologist is more sensitive.
❓ Frequently Asked Questions
Q: My child has VSD. What is the chance that my next child will also have a heart defect?
For an isolated VSD in an otherwise healthy child with no family history, the recurrence risk for the next sibling is approximately 2–3% — compared to the general population risk of about 1%. This is modestly elevated but still means there is a 97% chance the next child will have a normal heart. A fetal echocardiogram around 20–22 weeks in the next pregnancy is recommended to check.
Q: My child has Down syndrome and a heart defect — does that mean my next child will too?
Down syndrome is caused by Trisomy 21 — an extra copy of chromosome 21. In most cases this is a random event (non-disjunction during egg or sperm formation) and the recurrence risk is low, approximately 1–1.5% above the baseline age-related risk. For women under 30 with no chromosomal abnormality themselves, this is very low. Genetic counselling before the next pregnancy is helpful for clarifying the exact risk based on your specific situation.
Q: My child has been diagnosed with 22q11 deletion (DiGeorge syndrome). What does this mean for my family?
22q11.2 deletion is autosomal dominant — each child of an affected person has a 50% chance of inheriting the deletion. However, around 90% of cases arise as new (de novo) mutations in the child, not inherited from a parent. Before assuming familial risk, both parents should be tested for the 22q11 deletion. If neither parent carries it, the recurrence risk in future siblings is very low (<1%). If one parent carries it, each future sibling has a 50% chance.
Q: When my child grows up and wants to have children — what should we tell them?
That conversation will be different depending on the diagnosis. For multifactorial isolated CHD, the risk to their future children is approximately 3–5% — elevated but manageable with fetal echo monitoring. For autosomal dominant conditions (HCM, LQTS, 22q11), the risk is 50% and genetic counselling and preconception planning are important. The time for this conversation is adolescence — so your child understands their own health fully before family planning. Your cardiologist can refer to clinical genetics.
Q: We are cousins — does consanguinity increase the risk of CHD in our children?
Consanguinity increases the overall risk of autosomal recessive conditions — conditions where both copies of a gene must be abnormal for the disease to appear. Isolated CHD is mostly multifactorial, so consanguinity increases risk modestly. However, if there are other affected family members or the child has a complex CHD, the risk of an underlying recessive genetic cause is higher and warrants genetic evaluation. Fetal echo in the pregnancy is advisable regardless.
🎯 Key Takeaways
- CHD genetics depends entirely on the specific diagnosis — the answer is different for VSD vs. HCM vs. Down syndrome vs. LQTS.
- Most isolated CHDs (VSD, ASD, TOF, etc.) are multifactorial — the recurrence risk for the next sibling is 2–3%, not 50%.
- Chromosomal syndromes (Down, Turner, DiGeorge) need specific testing to clarify recurrence risk — it is not the same for all.
- Autosomal dominant conditions (HCM, LQTS, Marfan, 22q11) carry a 50% risk per child — genetic counselling is essential.
- Fetal echocardiography at 20–22 weeks is recommended in all subsequent pregnancies when a first-degree relative has CHD.
- A referral to a clinical genetics service is one of the most valuable things a family of a child with CHD can receive.
📚 References & Sources
Allen HD et al. Moss & Adams’ Heart Disease in Infants, Children, and Adolescents, 10th Ed. Wolters Kluwer, 2022.
Pierpont ME et al. Genetic Basis for Congenital Heart Disease: Revisited. Circulation 2018;138(21):e653–e711.
Blue GM et al. Congenital Heart Disease: Current Knowledge About Causes and Inheritance. Med J Aust 2012;197(3):155–159.
© PedHeartIndia | www.pedheartindia.com — Educational purposes only.
A note from Dr. Sunil: This article is general educational information and is not a substitute for personal medical advice. For any concern about your child’s heart, please see a qualified doctor in person.
